Skip to content

Postoperative pain management in hysterectomy patient

Postoperative quality of recovery after hysterectomy in patient on Duloxetine - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071886
Enrollment
62
Registered
2024-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: 1.The Quality of Recovery (QoR)-40 questionnaire 2. Visual Analogue Score 3. Opioid analgesic consumption doses 4. Adverse Events: To observe the effect of administration of per

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with benign gynaecologic conditions (fibroids, pelvic pain, uterine prolapse) who are planned to undergo hysterectomy under spinal anaesthesia. 2. Female patients older than 18 years with ASA I or II.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic non-gynaecologic conditions (liver or pulmonary disease, diabetes mellitus) 2. The history of use of psychotropic drugs (anti-depressants, neuroleptics, lithium) in the last 1 year. 3. Those with Duloxetine allergy. 4. Patients using opioids for gynaecologic or non-gynaecologic conditions.

Design outcomes

Primary

MeasureTime frame
1. Quality of Recovery-40 questionnaire total score 2. Visual Analogue scoreTimepoint: Both the respective Groups will be assessed Postoperatively at 6th, 12th and 24th hours after the surgery.

Secondary

MeasureTime frame
1. Opioid analgesic consumption doses (Fentanyl) 2. Adverse EventsTimepoint: 1. Opioid analgesic consumption (fentanyl) doses 24 hours after surgery 2. Adverse Events During stay in postoperative ward at 48 hours

Countries

India

Contacts

Public ContactDr Sumesh T Rao

kasturba medical college, mangalore

sumesh.rao@manipal.edu9449167895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026